Press release
Global Chronic Cough Industry Outlook 2025-2029: Market Set to Cross $12.83 Billion Milestone
Chronic Cough
How Large Will the Chronic Cough Market Size By 2025?
The market addressing chronic cough has experienced robust expansion lately, projected to increase from $8.22 billion in 2024 to $8.87 billion in 2025, reflecting an 8.0% compound annual growth rate; this upward trend during the past period stems from factors like the widespread occurrence of associated respiratory illnesses, atmospheric conditions and contamination, the habit of smoking and consuming tobacco, various respiratory ailments, and the presence of allergies and environmental sensitivities.
How Big Is the Chronic Cough Market Size Expected to Grow by 2029?
The overall valuation of the chronic cough sector is projected to experience substantial expansion over the forthcoming years, reaching an estimated $12.83 billion by 2029, propelled by a compound annual growth rate (CAGR) of 9.7%; this upward trajectory is fundamentally supported by the development of novel treatments aimed at distinct physiological pathways, a deepening comprehension of cough etiology linked to reflux, worldwide initiatives aimed at reducing tobacco use, and the implementation of health regulations concerning occupational and environmental exposures, while key movements shaping this market involve progress in diagnostic tools, a shift towards care models centered on the patient, breakthroughs in treating neurogenic cough, the utilization of remote monitoring for managing ongoing cough issues, and ongoing investigations into central sensitization mechanisms.
View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report
Which Key Market Drivers Powering Chronic Cough Market Expansion and Growth?
An anticipated escalation in the frequency of coughing episodes is forecasted to stimulate the expansion of the chronic cough market moving ahead. Cough, defined as a sudden, forceful expulsion of air from the lungs, serves as a protective reflex primarily triggered by irritants, mucus buildup, or foreign matter obstructing the airways. When a cough endures for a minimum duration of eight weeks, it is then classified as chronic; consequently, an increase in general cough occurrences directly translates to a higher burden of chronic cough cases. To illustrate this trend, data from the Florida Health agency in the US indicated that during 2021, 80 such incidents were observed, corresponding to rates of 41.0 and 1.4 per 100,000 person-years. Moreover, a separate count revealed that 28 instances of pertussis were documented across 13 nations in 2023. Adding to this evidence, the Statens Serum Institut in Denmark reported that between November 2022 and April 2023, cases of pertussis saw a significant surge of 41% when contrasted with the November 2021 to April 2022 period in the country. Thus, the increasing incidence of coughing broadly underpins the forward momentum of the chronic cough commercial sector.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Chronic Cough Market?
Key players within the chronic cough market are focusing their efforts on developing novel offerings, including biosimilars, as a means to solidify their standing. These biosimilar drugs represent economical substitutes for established biologics and are utilized in managing ailments such as diabetes, cancer, and various autoimmune disorders. A concrete illustration is Sandoz, a pharmaceutical enterprise headquartered in Switzerland, which in July 2024 introduced its biosimilar Pyzchiva (ustekinumab) throughout European territories, specifically targeting chronic inflammatory conditions including Crohn's disease, psoriatic arthritis, and plaque psoriasis. This particular biosimilar marks a notable milestone because it is the very first offering in Europe accessible across all specified strengths of the reference medication, encompassing the initial dosage required for Crohn's disease treatment. Through the collaboration with Samsung Bioepis, Sandoz intends to broaden availability of successful therapies for the vast number of individuals suffering from these illnesses, with this launch underscoring the company's dedication to delivering accessible healthcare options and ultimately elevating patient living standards across Europe.
What Are the Emerging Segments in the Chronic Cough Market?
The chronic coughmarket covered in this report is segmented -
1) By Drug Class: Antihistamines; Corticosteroids; Decongestants; Combination Drug; Antibiotics; Acid Blockers; Other Drug Classes
2) By Route Of Administration: Oral; Inhalational; Injectable; Other Route Of Administrations
3) By End-Users: Hospitals; Homecare; Specialty Centers; Other End Users
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
Subsegments:
1) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines
2) By Corticosteroids: Inhaled Corticosteroids; Systemic Corticosteroids
3) By Decongestants: Oral Decongestants; Nasal Decongestants
4) By Combination Drug: Antihistamine And Decongestant Combinations; Cough Suppressant And Expectorant Combinations
5) By Antibiotics: Macrolides; Penicillins; Cephalosporins
6) By Acid Blockers: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists
7) By Other Drug Classes: Mucolytics; Cough Suppressants; Herbal Remedies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12109&type=smp
Who Are the Global Leaders in the Chronic Cough Market?
Major companies operating in the chronic cough market include Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Glaxo SmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.
Which are the Top Profitable Regional Markets for the Chronic Cough Industry?
North America was the largest region in the chronic cough market in 2024. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12109
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Chronic Cough Industry Outlook 2025-2029: Market Set to Cross $12.83 Billion Milestone here
News-ID: 4270791 • Views: …
More Releases from The Business Research Company
Segment Analysis And Key Growth Categories In The Disc Sterilizer Steam Market
The disc sterilizer steam market is poised for notable expansion in the coming years, driven by advances in healthcare and biotechnology sectors. With growing emphasis on infection control and medical safety, this industry is evolving rapidly, supported by technological innovations and increasing healthcare investments around the world. Below is an in-depth look at the current market size, leading players, emerging trends, and segmentation details shaping this market's future trajectory.
Projected Market…
New Growth Trends Accelerating Expansion In The Dental Practice Revenue Analytic …
The dental practice revenue analytics market is poised for significant advancement as dental care providers increasingly embrace technological solutions to enhance their financial and operational performance. With the integration of innovative analytics tools, the sector is set to transform how dental practices manage revenue and patient outcomes. Let's delve into the market size projections, key players, notable trends, and segment details shaping this evolving industry.
Projected Growth and Market Size of…
Segmentation Overview, Market Dynamics, And Competitive Positioning In The DC Wa …
The market for DC wallbox chargers is set for a remarkable expansion as electric vehicles (EVs) continue to gain popularity and demand for efficient charging infrastructure rises. With technological innovations and growing collaborations shaping the landscape, this sector is on track to transform how EVs integrate with energy systems. Let's explore the market size, key players, emerging trends, and segmentation details that define the future of DC wallbox chargers.
Steady Market…
Segment Analysis And Key Growth Categories In The Contrast Therapy Equipment Mar …
The contrast therapy equipment market is on track for significant expansion as demand for innovative recovery and rehabilitation solutions continues to rise. Driven by technological advancements and growing interest in health and fitness, this sector is expected to witness robust growth in the coming years. Below, we explore the market size, key players, emerging trends, and segment details shaping the landscape.
Projected Growth and Size of the Contrast Therapy Equipment Market
The…
More Releases for Cough
Dog's Cough Intensifies Due to Temperature Difference, Trusted Dog Cough Medicin …
Image: https://www.getnews.info/uploads/e50cc9d317e270f5e3e669a0339f0b84.jpg
During periods of significant temperature fluctuations, not only humans but also many dogs are prone to experiencing coughing symptoms. Differences between daytime and nighttime temperatures, dry weather, and frequent transitions between indoor and outdoor environments can directly affect the bronchial health of dogs, making them more susceptible to respiratory problems. In particular, sudden changes in weather can make a dog's respiratory system sensitive, resulting in noticeable coughing symptoms.
Coughing in…
Cough Care Advance launches Cough Care Advance, an innovative, kid-friendly coug …
Cough Care Advance is introducing an innovative, kid-friendly cough remedy that provides safe, natural, and long-lasting relief.
Parents know how difficult it can be when children are battling a stubborn cough. Whether it's keeping them up at night or disrupting their day at school, finding an effective and gentle solution is a top priority. That's why Cough Care Advance is introducing an innovative, kid-friendly cough remedy that provides safe, natural, and…
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991
This latest report researches the…
Refractory Chronic Cough Therapeutics Market - Pioneering Solutions for Persiste …
Newark, New Castle, USA - new report, titled Refractory Chronic Cough Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Refractory Chronic Cough Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Refractory Chronic Cough Therapeutics market. The report offers…
Cough Systems Market
Global cough systems market size is expected to be worth roughly USD 192.8 million by 2030, growing at a CAGR of more than 8.6% during the projected timeframe of 2022-2030, according to Ameco Research
Cough systems are appliances that assist to cleanse the lungs of excessive cough output by changing the flow patterns, which enhances the airway patency and helps to establish and promote alveolar growth. Excessive coughing produces severe lung…
Global Cough Syrup Market Size, Cough Syrup Market Share, Cough Syrup Market Gro …
The Global "Cough Syrup Market" 2022 research report presents an in-depth analysis of the Cough Syrup Market size, growth, share, segments, manufacturers, and forecast, competition landscape and growth opportunity. The research's goal is to provide market data and strategic insights to help decision-makers to make educated investment decisions while also identifying potential gaps and development possibilities.We also analysed the impact of COVID-19 (Corona Virus) on the product industry chain based…
